Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019 Article

Balmaceda, Nicole, Aziz, Muhammad, Chandrasekar, Viveksandeep Thoguluva et al. (2021). Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019 . BMC CANCER, 21(1), 10.1186/s12885-021-08451-x

Open Access

cited authors

  • Balmaceda, Nicole; Aziz, Muhammad; Chandrasekar, Viveksandeep Thoguluva; McClune, Brian; Kambhampati, Suman; Shune, Leyla; Abdallah, Al-Ola; Anwer, Faiz; Majeed, Aneela; Qazilbash, Muzaffar; Ganguly, Siddhartha; McGuirk, Joseph; Mohyuddin, Ghulam Rehman

sustainable development goals

authors

publication date

  • June 26, 2021

published in

keywords

  • Anti-CD38
  • BORTEZOMIB
  • Cytotoxic therapy
  • DARATUMUMAB
  • HIGH-DOSE DEXAMETHASONE
  • Infection
  • Life Sciences & Biomedicine
  • MELPHALAN
  • Multiple myeloma
  • OPEN-LABEL
  • Oncology
  • PHASE-3
  • PLUS LENALIDOMIDE
  • POMALIDOMIDE
  • PREDNISONE
  • Proteasome inhibitors
  • Science & Technology
  • THERAPY

Digital Object Identifier (DOI)

publisher

  • BMC

volume

  • 21

issue

  • 1